Article

Novel proteomics test detects 95% of prostate cancers

Bethesda, MD-A screening technique based on the interplay of blood proteinsmay help clearly differentiate between prostate cancer and benign conditionslike BPH, according to a National Cancer Institute study. The test, whichis still under investigation, showed a specificity of 71% in men with marginallyelevated PSA levels, NCI researchers reported.

Related Videos
Yahir A. Santiago-Lastra, MD, answers a question during a Zoom video interview
Woman talking with a doctor | Image Credit: © Liudmila Dutko - stock.adobe.com
Karyn S. Eilber, MD, answers a question during a Zoom video interview
Anna Myers, CNP, answers a question during a Zoom video interview
Drug costs | Image Credit: © pixelrobot - stock.adobe.com
Raymond Xu, MD, answers a question during a Zoom video interview
Related Content
© 2025 MJH Life Sciences

All rights reserved.